Bissonnette RP, Cesario RM, Goodenow B, Shojaei F, et al. The epigenetic immunomodulator, HBI-8000, enhances the response and reverses resistance to checkpoint inhibitors. BMC Cancer 2021;21:969.
PMID: 34461854